A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder.

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Lexaria Bioscience (LEXX) has engaged a contract research organization to perform the world’s first-ever fluorescently tagged ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

The study noted that while semaglutide drugs “substantially decreased” the risk of hospitalization, the results were not associated with suicide attempts. (Irwin, 11/13) Yahoo Finance: Hims & Hers ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.